AHNS系列:您了解指南吗?头颈外科围手术期抗血栓管理
头颈外科患者常合并需抗血栓治疗的内科问题,围手术期需平衡血栓栓塞与出血风险。随机对照试验数据有限,术式特异性出血率难以确定,中高血栓风险患者接受高出血风险头颈肿瘤手术时决策尤为困难。择期手术可推迟以优化抗血栓药物,急诊手术则不能,且头颈手术后出血可能危及气道。
要点
- 头颈外科围手术期抗血栓管理需平衡血栓栓塞与出血风险。
- 随机对照试验数据有限,术式特异性出血率难以确定。
- 头颈手术后出血可能危及气道,增加管理挑战。
核心结论
- 头颈外科围手术期抗血栓管理缺乏随机对照试验数据,术式特异性出血率难以确定,决策需个体化平衡血栓栓塞与出血风险。
研究设计与样本
- 指南制定机构为AHNS(美国头颈学会),方法为系列指南解读,未报告系统检索方法或样本量。
主要发现
- 头颈外科患者常合并需抗血栓治疗的内科问题,围手术期平衡血栓栓塞与出血风险困难。
- 中高血栓栓塞风险患者接受高出血风险头颈肿瘤手术时决策尤为困难。
- 择期手术可推迟以优化抗血栓药物,急诊手术不能推迟。
- 头颈手术后出血可能危及气道,使管理更具挑战。
临床怎么用
- 头颈外科围手术期应评估患者血栓栓塞与出血风险,个体化制定抗血栓管理策略。
- 择期手术可考虑推迟以优化抗血栓药物,急诊手术需权衡风险紧急处理。
- 头颈手术后需警惕出血导致的气道风险。
局限性
- 随机对照试验数据有限,术式特异性出血率难以确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Head and neck surgeons are commonly faced with surgical patients who have underlying medical problems requiring antithrombotic therapy. It is difficult to achieve a balance between minimizing the risk of thromboembolism and hemorrhage in the perioperative period. Data from randomized, controlled trials are limited, and procedure-specific bleed rates are also difficult to pinpoint. The decision is made more difficult when patients with moderate-to-high risk for thromboembolic events undergo procedures that are high risk for bleeding. This is true for many head and neck oncologic surgeries. Furthermore, although elective procedures may be delayed for optimization of antithrombotic medication, emergent procedures cannot. Head and neck surgery often represents the most challenging of all these circumstances, given the potential risk of airway compromise from bleeding after head and neck surgery.
引用
- Meyer A, Gross N, Teng M, et al. AHNS Series: Do you know your guidelines? Perioperative antithrombotic management in head and neck surgery. Head Neck. 2017. PMID: 29044795. doi:10.1002/hed.24927
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。